HealthIT Answers December 8, 2021
As tradition, we have rounded up the industry leaders that have thoughts and predictions for what we might see in the new year. Join us for the next few weeks as we look at what we might see in 2022.
Rose Higgins, CEO, HealthMyne
Twitter: @HealthMyne
Clinical trial sponsors will increasingly rely on radiomics, the science of advanced imaging analytics, to enrich and inform clinical trials strategies, leading to deeper insights into patient populations. Using AI and machine learning to extract new types of data from traditional images such as CT and PET scans, radiomics enables researchers to develop more quantitative and robust inclusion and exclusion criteria, as well as predict patient outcomes. Additionally, radiomics offers tools to objectively quantify the...
Today's Sponsors
Today's Sponsor